1. Introduction & Epidermal Pathophysiology
Acne Vulgaris is a multifactorial inflammatory disease affecting the pilosebaceous units — complex cutaneous structures consisting of a hair follicle and its associated sebaceous gland. It represents one of the most prevalent skin conditions globally, affecting over 85% of adolescents aged 12–24 and persisting into adulthood for up to 50% of women and 40% of men.
The development of acne lesions involves four central pathogenic mechanisms that act synergistically: Follicular Hyperkeratinization leading to microcomedone obstruction, Androgen-mediated hyperseborrhea, Cutibacterium acnes colonization triggering Toll-like receptor 2 (TLR-2) activation, and the inflammatory cascade releasing IL-1α, IL-8, and TNF-α.
2. Clinical Classification & Severity Grading (Grade I to IV)
Dermatological practice categorizes acne into non-inflammatory comedonal and inflammatory subtypes:
- Grade I (Mild Comedonal): Open comedones (blackheads) and closed comedones (whiteheads) with minimal or absent inflammatory papules.
- Grade II (Mild-to-Moderate Papulopustular): Concomitant presence of comedones along with erythematous papules and superficial pustules limited to face and neck.
- Grade III (Moderate-to-Severe Nodular): Widespread inflammatory papules, extensive pustules, and early painful subcutaneous nodules prone to post-inflammatory erythema (PIE).
- Grade IV (Severe Nodulocystic & Acne Conglobata): Deep, interconnected, painful fluctuant cysts and draining sinus tracts carrying elevated risk of keloidal or atrophic scarring.
3. Evidence-Based Topical & Systemic Therapeutics
Clinical management adheres to international guidelines:
- Topical Retinoids (Adapalene 0.1–0.3%, Tretinoin 0.025–0.1%, Tazarotene 0.05–0.1%): Normalize follicular desquamation and downregulate inflammatory TLR expression.
- Antimicrobial Agents (Benzoyl Peroxide 2.5–5%): Delivers lipophilic bactericidal action against C. acnes without antimicrobial resistance induction.
- Systemic Antibiotics & Anti-Androgens: Oral Doxycycline (50–100mg daily) or Spironolactone for hormonal hyperseborrhea in adult females.
- Oral Isotretinoin: Indicated for severe nodulocystic disease, treatment-refractory cases, or rapid scarring progression.
4. Clinical AI Pre-Screening & Lesion Monitoring
Medicus Labs employs vision transformer backbones to map cutaneous surface topology, segment inflammatory vs non-inflammatory counts, and monitor treatment response objectively over time.